Skip to main content
. 2019 Nov 6;9:16104. doi: 10.1038/s41598-019-52616-5

Figure 1.

Figure 1

Identification of a tracrRNA with improved Cas9 RNP activity. (A) A schematic of the crRNA and tracrRNA. The target sequence is represented by N(20) in the crRNA. The boxed nucleotides are altered in tracrRNA-6 and 19. (B) A series of U-modified tracrRNAs (1–17) were annealed with a TAR6 crRNA and transfected into pMoHIV-C6 cells. GFP expression was assessed by FACS at 48 hours post-transfection. An unmodified tracrRNA-(tracrRNA-UM) was included as a comparative control. Untransfected cells (Mock) or a transfection without a dgRNA (control) were included as negative controls. (C) A serial dilution of the tracrRNA-6 and tracrRNA-UM were transfected into pMoHIV-C6 cells, and the levels of GFP were assessed by FACS. The embedded image reflects fold change in knock-down activity relative to the tracrRNA-UM at each dilution. (D) Total DNA was extracted 48 hours post-transfection and the percentage of indels was determined by drop-off assay using ddPCR. The embedded image reflects fold change in indels relative to the tracrRNA-UM at each dilution of the tracrRNA-6. The errors bars represent standard error of the mean (SEM) of duplicate treated samples and experiments performed in duplicate, and the experiment was repeated twice.*p < 0.05, ***p < 0.001 were obtained by one-way ANOVA and Dunnett’s test.